SingleTimeMicroneedles


Developer of a transdermal microneedle patch platform designed for single-application, multi-dose and time-release delivery of drugs, vaccines, and supplements. The platform emphasizes thermal stability to reduce cold-chain requirements, dissolving microneedle delivery to avoid sharps waste, and adaptable formulations for human, animal, and nutraceutical applications. Research, preclinical results, and academic collaborations are highlighted as supporting evidence.

Industries

biopharma
biotechnology
pharmaceutical

Nr. of Employees

small (1-50)

SingleTimeMicroneedles

1392 Storrs Road. Unit 4213, Room 101/101A, Storrs, CT 06269, US


Products

Transdermal microneedle patch platform

A single-application patch platform that delivers drugs, vaccines, or supplements via dissolving microneedles with programmable multi-dose/time-release profiles and thermal-stable formulations suitable for human, veterinary, and nutraceutical applications.

Expertise Areas

  • Transdermal microneedle systems
  • Controlled-release delivery
  • Thermal stabilization of vaccines and biologics
  • Vaccine delivery for human and animal health
  • Show More (3)

Key Technologies

  • Dissolving microneedle arrays
  • Programmable/multi-burst release systems
  • Thermal stabilization via excipient/formulation
  • Transdermal formulation development
  • Show More (2)

News & Updates

Peer-reviewed publication describing a single-administration microneedle patch for self-boosting delivery in obesity treatment (authors and 2024 date cited on site).

Publication describing a microneedle patch engineered for multi-burst vaccine release against SARS-CoV-2 (Advanced Materials Technologies, 2022).

Nature Biomedical Engineering paper on programmable burst release using transdermal microneedles (2020).

Voted audience winner at a Kisaco Animal Health and Nutrition and Technology Innovation conference; cited as validation of the platform's market fit and scalability.

Winner in the Food, Nutrition, and Health category at South by Southwest 2024 for the microneedle patch platform.

Collaboration with university researchers reporting thermal stabilization of microneedle vaccine formulations using sugar-molecule stabilization to reduce cold-chain dependence.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.